ABSTRACT
SARS-CoV-2 emerged in the UK in January 2020 and the Government introduced national ‘lockdowns’ and regional ‘tiers’ to control virus transmission. As the outbreak continued, new variants were detected. We analysed spatio-temporal dynamics of positive tests for COVID-19 on Teesside, UK throughout 2020, in relation to: socio-economic deprivation, weather, and Government interventions. We used a combination of disease mapping and mixed-effect modelling to investigate the dynamics of positive tests from two sampling strategies and the spread of particular variants of the virus as they emerged on Teesside. SARS-CoV-2 spread was related to the extent of social deprivation, lockdown interventions and weather. SARS-CoV-2 spread faster in some lineages than others, with positive tests related to levels of socio-economic deprivation. The interventions appeared to have different effects in the two waves of disease, and were associated with reduced numbers of records in the first wave, but having no effect during the second.
ARTICLE SUMMARY LINE Regional spread of SARS-CoV-2 is dependent on weather, socio-economic and mandatory lockdowns, but the effectiveness of the latter varies with virus lineage.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded under COG-UK; this is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR) [grant code: MC_PC_19027], and Genome Research Limited, operating as the Wellcome Sanger Institute.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Covid-19 Genomics UK Consortium (COG-UK) https://www.cogconsortium.uk
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵** See Supplementary Information for full list of Covid-19 Genomics UK Consortium names and affiliations.
Minor change to formatting of Abstract
Data Availability
All data produced in the present study are available upon reasonable request to the authors